BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24627538)

  • 1. Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled study.
    Eskandari D; Zou D; Karimi M; Stenlöf K; Grote L; Hedner J
    Eur Respir J; 2014 Jul; 44(1):140-9. PubMed ID: 24627538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetazolamide Reduces Blood Pressure and Sleep-Disordered Breathing in Patients With Hypertension and Obstructive Sleep Apnea: A Randomized Controlled Trial.
    Eskandari D; Zou D; Grote L; Hoff E; Hedner J
    J Clin Sleep Med; 2018 Mar; 14(3):309-317. PubMed ID: 29510792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of Provent on moderate to severe obstructive sleep apnoea during continuous positive airway pressure therapy withdrawal: a randomised controlled trial.
    Rossi VA; Winter B; Rahman NM; Yu LM; Fallon J; Clarenbach CF; Bloch KE; Stradling JR; Kohler M
    Thorax; 2013 Sep; 68(9):854-9. PubMed ID: 23723343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiometabolic changes after continuous positive airway pressure for obstructive sleep apnoea: a randomised sham-controlled study.
    Hoyos CM; Killick R; Yee BJ; Phillips CL; Grunstein RR; Liu PY
    Thorax; 2012 Dec; 67(12):1081-9. PubMed ID: 22561530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with obstructive sleep apnea syndrome benefit from acetazolamide during an altitude sojourn: a randomized, placebo-controlled, double-blind trial.
    Nussbaumer-Ochsner Y; Latshang TD; Ulrich S; Kohler M; Thurnheer R; Bloch KE
    Chest; 2012 Jan; 141(1):131-138. PubMed ID: 21659435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of continuous positive airway pressure on endothelial function and circulating progenitor cells in obstructive sleep apnoea: a randomised sham-controlled study.
    Simpson PJ; Hoyos CM; Celermajer D; Liu PY; Ng MK
    Int J Cardiol; 2013 Oct; 168(3):2042-8. PubMed ID: 23453448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised controlled crossover trial of humidified continuous positive airway pressure in mild obstructive sleep apnoea.
    Marshall NS; Neill AM; Campbell AJ; Sheppard DS
    Thorax; 2005 May; 60(5):427-32. PubMed ID: 15860720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.
    Marin JM; Carrizo SJ; Vicente E; Agusti AG
    Lancet; 2005 Mar 19-25; 365(9464):1046-53. PubMed ID: 15781100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial.
    Durán-Cantolla J; Aizpuru F; Montserrat JM; Ballester E; Terán-Santos J; Aguirregomoscorta JI; Gonzalez M; Lloberes P; Masa JF; De La Peña M; Carrizo S; Mayos M; Barbé F;
    BMJ; 2010 Nov; 341():c5991. PubMed ID: 21106625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acetazolamide and autoCPAP therapy on breathing disturbances among patients with obstructive sleep apnea syndrome who travel to altitude: a randomized controlled trial.
    Latshang TD; Nussbaumer-Ochsner Y; Henn RM; Ulrich S; Lo Cascio CM; Ledergerber B; Kohler M; Bloch KE
    JAMA; 2012 Dec; 308(22):2390-8. PubMed ID: 23232895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The feasibility of using auto-titrating continuous positive airway pressure to treat obstructive sleep apnoea after acute tetraplegia.
    Berlowitz DJ; Spong J; Pierce RJ; Ross J; Barnes M; Brown DJ
    Spinal Cord; 2009 Dec; 47(12):868-73. PubMed ID: 19488050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial.
    Chapman JL; Kempler L; Chang CL; Williams SC; Sivam S; Wong KK; Yee BJ; Grunstein RR; Marshall NS
    Thorax; 2014 Mar; 69(3):274-9. PubMed ID: 24287166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of nasal positive end expiratory pressure valve as an alternative treatment for obstructive sleep apnoea in Chinese patients.
    To KW; Chan TO; Ng S; Ngai J; Hui DS
    Respirology; 2016 Apr; 21(3):541-5. PubMed ID: 26640077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Follow-up examination and probatory CPAP therapy of obstructive sleep apnoea increase the long-term compliance].
    Wenzel M; Neifer C; Wenzel G; Kerl J; Jürgens K; Suchi S; Köhler D
    Pneumologie; 2008 Feb; 62(2):75-9. PubMed ID: 18200453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diurnal changes and levels of fibrin generation are not altered by continuous positive airway pressure (CPAP) in obstructive sleep apnoea (OSA). A randomised, placebo-controlled crossover study.
    McEwen BJ; Phillips CL; Morel-Kopp MC; Yee BJ; Sullivan DR; Ward CM; Tofler GH; Grunstein RR
    Thromb Haemost; 2012 Oct; 108(4):701-9. PubMed ID: 22918526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients.
    Ferland A; Poirier P; Sériès F
    Eur Respir J; 2009 Sep; 34(3):694-701. PubMed ID: 19357147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desipramine improves upper airway collapsibility and reduces OSA severity in patients with minimal muscle compensation.
    Taranto-Montemurro L; Sands SA; Edwards BA; Azarbarzin A; Marques M; de Melo C; Eckert DJ; White DP; Wellman A
    Eur Respir J; 2016 Nov; 48(5):1340-1350. PubMed ID: 27799387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of nasal tramazoline with dexamethasone in obstructive sleep apnoea patients.
    Koutsourelakis I; Minaritzoglou A; Zakynthinos G; Vagiakis E; Zakynthinos S
    Eur Respir J; 2013 Oct; 42(4):1055-63. PubMed ID: 23397296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea.
    Arias MA; García-Río F; Alonso-Fernández A; Hernanz A; Hidalgo R; Martínez-Mateo V; Bartolomé S; Rodríguez-Padial L
    Eur Respir J; 2008 Oct; 32(4):1009-15. PubMed ID: 18508832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous positive airway pressure treatment for obstructive sleep apnoea reduces resting heart rate but does not affect dysrhythmias: a randomised controlled trial.
    Craig S; Pepperell JC; Kohler M; Crosthwaite N; Davies RJ; Stradling JR
    J Sleep Res; 2009 Sep; 18(3):329-36. PubMed ID: 19549077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.